Sample brain SPECT compounds and applications

NuclideHalf-LifeCompoundAcronymMeasurement
133Xe5.24 days133Xenon133XerCBF
123I13.2 hours123I-isopropyliodoamphetamine123I-IMPrCBF
Tc99m6.02 hoursTc99m-hexamethylpropyleneamineoximeTc99m-HMPAOrCBF
Tc99m6.02 hoursTc99m-ethyl cysteinate dimer (bicisate)Tc99m-ECDrCBF
Tc99m6.02 hoursTc99m-diethylenetriaminepentaacetic acidTc99m-DTPACSF, brain death
Tc99m6.02 hoursTc99m-pertechnetateTc99m-TcO4CSF, brain death
111In2.83 days111In-diethylenetriaminepentaacetic acid111In-DTPACSF, brain death
67Ga78.3 hours67Ga-ethylenediaminetetraacetic acid67Ga-EDTABlood-brain barrier permeability
123I13.2 hours123Iomazenil123I-IMZCentral type benzodiazepine-receptor binding20
123I13.2 hours123I-2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine123I-ADAMSerotonin transporter imaging21
123I13.2 hours123I-ß-carbomethoxy-3-ß-(4-iodophenyl)-tropane123I-CITDopamine and serotonin transporters22
123I13.2 hours123I-iodobenzofuran123I-IBFDopamine D-2 receptor ligand23
123I13.2 hours123I-iodobenzamide123I-IBZMDopamine D-2 receptor ligand24,25
Tc99m6.02 hoursTc99m-TRODATTc99m-TRODATDopamine transporter sites26
Tc99m6.02 hoursTc99m-pyrophosphateTc99m-PPiBone scanning, TMJ27,28
Tc99m6.02 hoursTc99m-methylene diphosphonateTc99m-MDPBone scanning, TMJ28,29
111In2.83 days[111In-DOTA0,D-Phe1,Tyr3] octreotide111In-DOTA-TOCSomatostatin receptor imaging30
Tc99m6.02 hoursTc99m-hydrazinonicotinyl-Tyr3-octreotideTc99m-HYNIC-TOCSomatostatin receptor imaging
111In2.83 days111In-pentetreotide111In-pentetreotideSomatostatin receptor imaging31
123I13.2 hours[123I]5-iodo-3-[2(S)-2-azetidinylmethoxy]pyridine123I-5IANicotinic acetylcholine receptors32
123I13.2 hours6-iodo-2-(4′-dimethylamino-)phenylimidazo[1,2-a]pyridine123I-IMPYβ-amyloid plaque imaging33
  • Note:—TMJ indicates temporomandibular joint; CBF, relative cerebral blood flow; TRODAT, [2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2-yl]methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-N2,N2′,S2,S2′]oxo-[1R-(exo-exo)].